A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer

Clinical trial NCT02105350 · WITHDRAWN

Trial details

NCT number: NCT02105350
Sponsor: University Health Network, Toronto
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Biliary Tract Carcinoma Gallbladder Carcinoma

Start date: 2015-06-01
Primary completion: 2015-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.